Mursch-Edlmayr Anna S, Ng Wai Siene, Diniz-Filho Alberto, Sousa David C, Arnold Louis, Schlenker Matthew B, Duenas-Angeles Karla, Keane Pearse A, Crowston Jonathan G, Jayaram Hari
Department of Ophthalmology Johannes Kepler University, Linz, Austria.
Cardiff Eye Unit, University Hospital of Wales, Cardiff, UK.
Transl Vis Sci Technol. 2020 Oct 15;9(2):55. doi: 10.1167/tvst.9.2.55. eCollection 2020 Oct.
This concise review aims to explore the potential for the clinical implementation of artificial intelligence (AI) strategies for detecting glaucoma and monitoring glaucoma progression.
Nonsystematic literature review using the search combinations "Artificial Intelligence," "Deep Learning," "Machine Learning," "Neural Networks," "Bayesian Networks," "Glaucoma Diagnosis," and "Glaucoma Progression." Information on sensitivity and specificity regarding glaucoma diagnosis and progression analysis as well as methodological details were extracted.
Numerous AI strategies provide promising levels of specificity and sensitivity for structural (e.g. optical coherence tomography [OCT] imaging, fundus photography) and functional (visual field [VF] testing) test modalities used for the detection of glaucoma. Area under receiver operating curve (AROC) values of > 0.90 were achieved with every modality. Combining structural and functional inputs has been shown to even more improve the diagnostic ability. Regarding glaucoma progression, AI strategies can detect progression earlier than conventional methods or potentially from one single VF test.
AI algorithms applied to fundus photographs for screening purposes may provide good results using a simple and widely accessible test. However, for patients who are likely to have glaucoma more sophisticated methods should be used including data from OCT and perimetry. Outputs may serve as an adjunct to assist clinical decision making, whereas also enhancing the efficiency, productivity, and quality of the delivery of glaucoma care. Patients with diagnosed glaucoma may benefit from future algorithms to evaluate their risk of progression. Challenges are yet to be overcome, including the external validity of AI strategies, a move from a "black box" toward "explainable AI," and likely regulatory hurdles. However, it is clear that AI can enhance the role of specialist clinicians and will inevitably shape the future of the delivery of glaucoma care to the next generation.
The promising levels of diagnostic accuracy reported by AI strategies across the modalities used in clinical practice for glaucoma detection can pave the way for the development of reliable models appropriate for their translation into clinical practice. Future incorporation of AI into healthcare models may help address the current limitations of access and timely management of patients with glaucoma across the world.
本简要综述旨在探讨人工智能(AI)策略在青光眼检测及监测青光眼进展方面临床应用的潜力。
采用“人工智能”“深度学习”“机器学习”“神经网络”“贝叶斯网络”“青光眼诊断”及“青光眼进展”等检索词组合进行非系统性文献综述。提取有关青光眼诊断和进展分析的敏感性和特异性信息以及方法学细节。
众多AI策略在用于青光眼检测的结构(如光学相干断层扫描[OCT]成像、眼底照相)和功能(视野[VF]检测)检查方式中展现出了较高的特异性和敏感性。每种检查方式的受试者操作特征曲线下面积(AROC)值均大于0.90。已证明结合结构和功能输入可进一步提高诊断能力。关于青光眼进展,AI策略能够比传统方法更早地检测到进展,甚至可能仅通过一次VF检测就能做到。
应用于眼底照相进行筛查的AI算法,通过一种简单且广泛可用的检测方法可能会取得良好效果。然而,对于可能患有青光眼的患者,应使用更复杂的方法,包括来自OCT和视野检查的数据。其结果可作为辅助手段协助临床决策,同时提高青光眼护理的效率、生产力和质量。已确诊青光眼的患者可能会从未来评估其进展风险的算法中受益。仍有待克服诸多挑战,包括AI策略的外部有效性、从“黑箱”向“可解释AI”的转变以及可能存在的监管障碍。然而,很明显AI能够增强专科临床医生的作用,并将不可避免地塑造青光眼护理的下一代未来模式。
AI策略在临床实践中用于青光眼检测的各种检查方式上所报告的有前景的诊断准确性水平,可为开发适用于转化为临床实践的可靠模型铺平道路。未来将AI纳入医疗保健模式可能有助于解决全球范围内青光眼患者目前在可及性和及时管理方面的局限性。